• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question.

作者信息

Lowenstern Angela, Newby L Kristin

机构信息

Division of Cardiology, Department of Medicine and the Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.

Division of Cardiology, Department of Medicine and the Duke Clinical Research Institute, Duke University Medical Center, Durham, NC

出版信息

J Am Heart Assoc. 2017 Sep 22;6(9):e007288. doi: 10.1161/JAHA.117.007288.

DOI:10.1161/JAHA.117.007288
PMID:28939720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5634319/
Abstract
摘要

相似文献

1
To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question.是否（使用口服P2Y12拮抗剂）进行预处理？这是个问题。
J Am Heart Assoc. 2017 Sep 22;6(9):e007288. doi: 10.1161/JAHA.117.007288.
2
Precatheterization Use of P2Y Inhibitors in Non-ST-Elevation Myocardial Infarction Patients Undergoing Early Cardiac Catheterization and In-Hospital Coronary Artery Bypass Grafting: Insights From the National Cardiovascular Data Registry.经皮冠状动脉介入治疗术前应用 P2Y12 抑制剂对行早期心脏导管检查和院内冠状动脉旁路移植术的非 ST 段抬高型心肌梗死患者的影响：来自全国心血管数据注册库的分析。
J Am Heart Assoc. 2017 Sep 22;6(9):e006508. doi: 10.1161/JAHA.117.006508.
3
Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).急性冠状动脉综合征行经皮冠状动脉介入治疗患者中当代口服抗血小板治疗指南的实施：来自希腊抗血小板登记研究（GRAPE）的报告。
Int J Cardiol. 2013 Oct 15;168(6):5329-35. doi: 10.1016/j.ijcard.2013.08.007. Epub 2013 Aug 15.
4
Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization.接受和未接受经皮冠状动脉血运重建治疗的急性冠状动脉综合征女性和男性的结局。
J Am Heart Assoc. 2017 Jan 20;6(1):e004319. doi: 10.1161/JAHA.116.004319.
5
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).伴有非ST段抬高型心肌梗死的糖尿病合并多支冠状动脉疾病患者的血运重建趋势：来自国家心血管数据注册库急性冠状动脉治疗和干预结果网络注册库-遵循指南行动（NCDR ACTION注册库-GWTG）的见解
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.
6
New antiplatelet agents in the treatment of acute coronary syndromes.新型抗血小板药物治疗急性冠脉综合征。
Arch Cardiovasc Dis. 2014 Mar;107(3):178-87. doi: 10.1016/j.acvd.2014.01.009. Epub 2014 Mar 11.
7
Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting: A Prospective, Randomized, Crossover Trial.比较替格瑞洛与普拉格雷对需冠脉支架置入的非 ST 段抬高型急性冠脉综合征合并糖尿病患者炎症、血管功能和循环内皮祖细胞的影响：一项前瞻性、随机、交叉试验。
JACC Cardiovasc Interv. 2017 Aug 28;10(16):1646-1658. doi: 10.1016/j.jcin.2017.05.064.
8
Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina.急性冠脉综合征和稳定性心绞痛患者中 P2Y12 抑制剂预负荷的获益和风险。
J Thromb Thrombolysis. 2017 Oct;44(3):303-315. doi: 10.1007/s11239-017-1529-6.
9
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries.基于当代欧洲注册研究的 STEMI 患者中 P2Y12 受体抑制剂治疗的应用、患者选择和结局。
Eur Heart J Cardiovasc Pharmacother. 2016 Jul;2(3):152-67. doi: 10.1093/ehjcvp/pvw003. Epub 2016 Jan 27.
10
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations.欧洲急性冠脉综合征患者中 P2Y12 抑制剂的当代注册研究：概述和方法学考虑。
Eur Heart J Cardiovasc Pharmacother. 2015 Oct;1(4):232-44. doi: 10.1093/ehjcvp/pvv024. Epub 2015 May 12.

本文引用的文献

1
Precatheterization Use of P2Y Inhibitors in Non-ST-Elevation Myocardial Infarction Patients Undergoing Early Cardiac Catheterization and In-Hospital Coronary Artery Bypass Grafting: Insights From the National Cardiovascular Data Registry.经皮冠状动脉介入治疗术前应用 P2Y12 抑制剂对行早期心脏导管检查和院内冠状动脉旁路移植术的非 ST 段抬高型心肌梗死患者的影响：来自全国心血管数据注册库的分析。
J Am Heart Assoc. 2017 Sep 22;6(9):e006508. doi: 10.1161/JAHA.117.006508.
2
P2Y12-ADP receptor antagonists: Days of future and past.P2Y12 - ADP受体拮抗剂：过去与未来的日子。
World J Cardiol. 2016 May 26;8(5):327-32. doi: 10.4330/wjc.v8.i5.327.
3
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会非ST段抬高型急性冠状动脉综合征患者管理指南：执行摘要：美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Dec 23;130(25):2354-94. doi: 10.1161/CIR.0000000000000133. Epub 2014 Sep 23.
4
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.普拉格雷与氯吡格雷用于急性冠脉综合征未血运重建患者。
N Engl J Med. 2012 Oct 4;367(14):1297-309. doi: 10.1056/NEJMoa1205512. Epub 2012 Aug 25.
5
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.在心脏手术患者中用坎格雷洛桥接抗血小板治疗：一项随机对照试验。
JAMA. 2012 Jan 18;307(3):265-74. doi: 10.1001/jama.2011.2002.
6
2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.2011 年更新版胸外科医师学会和心血管麻醉医师学会的血液保护临床实践指南。
Ann Thorac Surg. 2011 Mar;91(3):944-82. doi: 10.1016/j.athoracsur.2010.11.078.
7
Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.经皮冠状动脉介入治疗患者中实验室高剂量氯吡格雷负荷治疗与常规预负荷治疗的效果比较：ARMYDA-5 PRELOAD（经皮冠状动脉介入治疗期间抗血小板治疗减少心肌损伤）随机试验结果。
J Am Coll Cardiol. 2010 Aug 10;56(7):550-7. doi: 10.1016/j.jacc.2010.01.067.
8
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention.急性心肌梗死及经皮冠状动脉介入治疗的治疗方法、趋势和结果
J Am Coll Cardiol. 2010 Jul 20;56(4):254-63. doi: 10.1016/j.jacc.2010.05.008.
9
Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines).非 ST 段抬高型心肌梗死患者住院期间冠状动脉旁路移植术的时间来自国家心血管数据注册中心 ACTION 注册研究-GWTG（急性冠状动脉治疗和干预结局网络注册研究-遵循指南）。
JACC Cardiovasc Interv. 2010 Apr;3(4):419-27. doi: 10.1016/j.jcin.2010.01.012.
10
Intravenous platelet blockade with cangrelor during PCI.经皮冠状动脉介入治疗（PCI）时，使用坎格雷洛进行静脉内血小板阻断。
N Engl J Med. 2009 Dec 10;361(24):2330-41. doi: 10.1056/NEJMoa0908629.